Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant — denies it is “pushing for a break-up.”

The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date.

CVS Health Corp.’s stock rose 2.6% Monday after a report surfaced of a meeting between the health-care company and its major hedge-fund investor, Glenview Capital Management. CVS’s stock rose $1.65 to $63.